Cargando…

The skin tissue is adversely affected by TNF-alpha blockers in patients with chronic inflammatory arthritis: a 5-year prospective analysis

OBJECTIVE: We evaluated the incidence of and the main risk factors associated with cutaneous adverse events in patients with chronic inflammatory arthritis following anti-TNF-α therapy. METHODS: A total of 257 patients with active arthritis who were taking TNF-α blockers, including 158 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Machado, Natalia P., dos Reis Neto, Edgard Torres, Soares, Maria Roberta M. P., Freitas, Daniele S., Porro, Adriana, Ciconelli, Rozana M., Pinheiro, Marcelo M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2013
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782714/ https://www.ncbi.nlm.nih.gov/pubmed/24141833 http://dx.doi.org/10.6061/clinics/2013(09)03

Ejemplares similares

Nutrient intakes related to osteoporotic fractures in men and women – The Brazilian Osteoporosis Study (BRAZOS)
por: Pinheiro, Marcelo M, et al.
Publicado: (2009)

Quality of life measurements in patients with osteoporosis and fractures
por: Madureira, Melisa M., et al.
Publicado: (2012)

Antioxidant intake among Brazilian adults - The Brazilian Osteoporosis Study (BRAZOS): a cross-sectional study
por: Medeiros Pinheiro, Marcelo, et al.
Publicado: (2011)

Alpha–blocker and apoptosis
por: Elterman, Dean S., et al.
Publicado: (2013)

CNS Demyelination with TNF-α Blockers
por: Kemanetzoglou, Elissavet, et al.
Publicado: (2017)

Incidence of active mycobacterial infections in Brazilian patients with chronic inflammatory arthritis and negative evaluation for latent tuberculosis infection at baseline - A longitudinal analysis after using TNFα blockers
por: Gomes, Carina Mori Frade, et al.
Publicado: (2015)

Disseminated tuberculosis infection and paradoxical reaction during antimycobacterial treatment related to TNF-alpha blocker agent Infliximab
por: Unlu, Mehmet, et al.
Publicado: (2014)

Behҫet’s Disease, and the Role of TNF-α and TNF-α Blockers
por: van der Houwen, Tim, et al.
Publicado: (2020)

The effectiveness and safety of TNF-alpha blockers in the treatment of early psoriatic arthritis: an Italian multicentre longitudinal observational pilot study
por: Scarpa, Raffaele, et al.
Publicado: (2011)

Use of Anti-TNF Alpha Blockers Can Reduce Operation Rate and Lead to Growth Gain in Pediatric Crohn's Disease
por: Woo, Min Hyung, et al.
Publicado: (2019)

Prolonged paradoxical reaction to anti-tuberculous treatment after discontinuation of TNF-alpha- blocker therapy with adalimumab. Rare clinical documentation
por: Falkenstern-Ge, Roger Fei, et al.
Publicado: (2014)

Identification of the Schistosoma mansoni TNF-Alpha Receptor Gene and the Effect of Human TNF-Alpha on the Parasite Gene Expression Profile
por: Oliveira, Katia C., et al.
Publicado: (2009)

Comparative Analysis of TNF-alpha, TNF-R1, and TNF-R2 in Patients with Low-impact Fractures Due to Osteoporosis
por: Teixeira, Abel Oliveira Marques, et al.
Publicado: (2023)

Liver and tumour tissue concentrations of TNF-alpha in cancer patients treated with TNF-alpha and melphalan by isolated liver perfusion.
por: Kuppen, P. J., et al.
Publicado: (1997)

Synovial Tissue Response to Treatment with TNF Blockers in Peripheral Spondyloarthritis
por: Paramarta, Jacqueline E, et al.
Publicado: (2011)

Rheumatoid Meningoencephalitis: A Feared Condition in the Era of TNF Blockers
por: Figueroa Rodriguez, Fernando, et al.
Publicado: (2018)

The Role of Alpha Blockers in Children with Dysfunctional Voiding
por: Austin, Paul F.
Publicado: (2009)

Alpha blockers for treatment of ureteric stones: systematic review and meta-analysis
por: Hollingsworth, John M, et al.
Publicado: (2016)

Immunologic adverse reactions of β-blockers and the skin
por: Tatu, Alin Laurentiu, et al.
Publicado: (2019)

Glycan and Peptide IgE Epitopes of the TNF-alpha Blockers Infliximab and Adalimumab - Precision Diagnostics by Cross-Reactivity Immune Profiling of Patient Sera
por: Homann, Arne, et al.
Publicado: (2017)

A Brazilian Cohort of Patients With Immuno-Mediated Chronic Inflammatory Diseases Infected by SARS-CoV-2 (ReumaCoV-Brasil Registry): Protocol for a Prospective, Observational Study
por: Marques, Claudia, et al.
Publicado: (2020)

Efficacy of TNF blockers from the perspective of growth velocity: slovak experience
por: Mrážik, Pavol, et al.
Publicado: (2014)

Quality of life as a prognostic marker in pulmonary arterial hypertension
por: Fernandes, Caio JCS, et al.
Publicado: (2014)

Isolated hepatic perfusion in the pig with TNF-alpha with and without melphalan.
por: Borel Rinkes, I. H., et al.
Publicado: (1997)

Association between TNF-Alpha (-857) Gene Polymorphism and Susceptibility to Tuberculosis
por: Anoosheh, S, et al.
Publicado: (2011)

Effect of alpha1-blockers on stentless ureteroscopic lithotripsy
por: Zhu, Jianguo, et al.
Publicado: (2016)

Predictive factors for alpha blocker use after transurethral prostatectomy: Can preoperative urodynamic outcome predict alpha blocker medication after surgery?
por: Kim, Sung Jin, et al.
Publicado: (2022)

The use of alpha-1 adrenergic blockers in children with distal ureterolithiasis: a systematic review and meta-analysis
por: Glina, F.P., et al.
Publicado: (2015)

Monitoring the effect of TNF-alpha inhibitors on laboratory parameters and adverse effects in different diseases: a retrospective, single-center study
por: Madani, Abdulaziz N., et al.
Publicado: (2022)

Effects of Resistance Training on Immunoinflammatory Response, TNF-Alpha Gene Expression, and Body Composition in Elderly Women
por: Macêdo Santiago, Luís Ângelo, et al.
Publicado: (2018)

Anti-TNF-alpha-induced lupus
por: De Bandt, Michel
Publicado: (2019)

TNF-alfa blockers- promising therapy for chronic uveitis in very young children
por: Tauber, T, et al.
Publicado: (2008)

The use of TNF-α blockers in psoriatic arthritis patients with latent tuberculosis infection
por: Atteno, Mariangela, et al.
Publicado: (2014)

Unleashing endogenous TNF-alpha as a cancer immunotherapeutic
por: Josephs, Steven F., et al.
Publicado: (2018)

Bioengineered Nanoparticles Loaded-Hydrogels to Target TNF Alpha in Inflammatory Diseases
por: Oliveira, Isabel Matos, et al.
Publicado: (2021)

Sustainability of TNF-blocker tapering in rheumatoid arthritis over 3 years: long-term follow-up of the STRASS (Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study) randomised controlled trial
por: Sigaux, Johanna, et al.
Publicado: (2017)

Rare and Serious Adverse Effects of Anti-Tumor Necrosis Factor-Alpha (TNF-α) Agents in Crohn’s Disease
por: Kim, Sun, et al.
Publicado: (2021)

TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness
por: Rossi, Stefania, et al.
Publicado: (2018)

PTEN gene & TNF-alpha in acute myocardial infarction
por: Mahmoud, Adel H., et al.
Publicado: (2019)

Stimulation of fibroblast chemotaxis by human recombinant tumor necrosis factor alpha (TNF-alpha) and a synthetic TNF-alpha 31-68 peptide
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_r1hkh5k4iis7a1ofnqpi7veh77